Ειδήσεις: GILEAD | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

24/03 20:46 defenseworld.net

E. Ohman J or Asset Management AB Increases Stock Holdings in Gilead Sciences, Inc. $GILD

E. Ohman J Asset Management AB Gilead Sciences stock holdings biopharmaceutical

24/03 19:32 yahoo.com

Gilead acquires first TCE asset with $2.2bn Ouro Medicines buyout

Gilead Ouro Medicines acquisition targeted cancer therapy oncology $2.2 billion

24/03 15:26 statnews.com

STAT+: Gilead to acquire immunology biotech, offers lifeline to Galapagos

Gilead immunology biotech drug pricing Trump U.S. healthcare foreign pricing

24/03 15:17 statnews.com

STAT+: Pharmalittle: We’re reading about a Trump drug pricing flaw, a Gilead deal, and more

Trump drug pricing Gilead deal campus blog coffee super shroom honey

24/03 12:20 deadline.com

The Testaments’ Team On Casting Chase Infiniti As Agnes & Hopes For Multiple Seasons

The Testaments Chase Infiniti Agnes Hulu Margaret Atwood Gilead

24/03 06:54 investing.com

Keymed Biosciences shares rise on $320 mln windfall from Gilead-Ouro deal

Keymed Biosciences Gilead Ouro windfall stock surge biotech

24/03 00:37 investing.com

Gilead to buy biotech firm Ouro Medicines in over $2 billion deal

Gilead Sciences Ouro Medicines acquisition biotech $2B oncology

24/03 00:28 investing.com

Gilead to buy Ouro Medicines for up to $2.2 billion

Gilead Ouro Medicines acquisition rare disease biotech $2.2 billion

23/03 18:42 investing.com

Gilead Sciences nears $2 billion Ouro Medicines acquisition - FT

Gilead Sciences Ouro Medicines acquisition oncology antibody‑drug conjugates precision medicine

23/03 18:42 investing.com

Gilead Sciences nears $2 billion Ouro Medicines acquisition - FT

Gilead Sciences Ouro Medicines acquisition oncology antibody‑drug conjugates precision medicine

Loading...